Evidence map›Paper›PMID 12089256›Full record

ArticleJournal of clinical microbiology2002

Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil.

Flávia Lúcia Piffano Costa Pellegrino, Lúcia Martins Teixeira, Maria da Glória Siqueira Carvalho Md, Simone Aranha Nouér, Márcia Pinto De Oliveira, Jorge Luiz Mello Sampaio, Andrea D'Avila Freitas, Adriana Lucia Pires Ferreira, Efigenia de Lourdes Teixeira Amorim Ed, Lee W Riley and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. EffluxPathogens (Basel, Switzerland) · 2020
    Article
  3. Article
  4. Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Flávia Lúcia Piffano Costa PellegrinoInstituto de Microbiologia, Universidade Federal do Rio de Janeiro, Brazil.
Lúcia Martins Teixeira
Maria da Glória Siqueira Carvalho Md
Simone Aranha Nouér
Márcia Pinto De Oliveira
Jorge Luiz Mello Sampaio
Andrea D'Avila Freitas
Adriana Lucia Pires Ferreira
Efigenia de Lourdes Teixeira Amorim Ed
Lee W Riley
Beatriz Meurer Moreira
Instituto Nacional de Higiene, Epidemiología y Microbiología · CUHospital Universitário Clementino Fraga Filho · BRUniversity of California, Berkeley · US

Funding

TUBERCULOSIS TRAINING AND RESEARCHD43TW000905 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI RILEY, LEE W · 1997 to 2002
$1.3M
FIC NIH HHS D43 TW000905
6 · The paper itself

Abstract

Multidrug-resistant Pseudomonas aeruginosa nosocomial infections are increasingly recognized worldwide. The existence of metallo-beta-lactamase- and extended-spectrum beta-lactamase-producing isolates exhibiting resistance to most beta-lactam antimicrobial agents greatly complicates the clinical management of patients infected with such isolates. Since 1998, P. aeruginosa isolates resistant to all commercially available antimicrobial agents have been detected at a university-affiliated public hospital in Rio de Janeiro, Brazil. The present study was designed to characterize the antimicrobial resistance profiles and the genetic diversity of the P. aeruginosa strains isolated at this hospital and four private hospitals in Rio de Janeiro. Between April 1999 and March 2000, 200 consecutive isolates were obtained and analyzed for antimicrobial resistance. The genetic diversity of a selected number of them was evaluated by pulsed-field gel electrophoresis and PCR with the ERIC-2 primer. A predominant genotype, designated genotype A, was identified among isolates from four of the five hospitals evaluated. Eighty-four ceftazidime-resistant isolates were evaluated for metallo-beta-lactamase production, which was detected in 20 (91%) of 22 genotype A isolates and 11 (18%) of 62 isolates belonging to other genotypes (P < 0.05). Two metallo-beta-lactamase-producing genotype A isolates also produced an extended-spectrum beta-lactamase. The occurrence of multidrug-resistant P. aeruginosa strains belonging to a unique genotype in different hospitals in Rio de Janeiro underscores the importance of the contribution of a single clone to the increase in the incidence of multidrug-resistant P. aeruginosa nosocomial infections.

Indexed as

beta-LactamasesBrazilCross InfectionDNA, BacterialDrug Resistance, BacterialDrug Resistance, MultipleElectrophoresis, Gel, Pulsed-FieldGenotypeHumansPseudomonas aeruginosaPseudomonas Infectionsbeta-LactamasesDNA, Bacterial

Identifiers

PMID12089256
PMCPMC120547
OpenAlexW2119814330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.